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Background Development and Training {#s001}
===================================

Dr. Kimura graduated from the University of Tokyo, Faculty of Pharmaceutical Sciences, in 1980 and received his PhD from the University of Tokyo in 1985. He studied neurotransmitters in the cerebellum using electrophysiological techniques at the National Defense Medical College ([@B33], [@B64]), and the gene structure of cytochrome P-450 at the Cancer Institute ([@B35], [@B36]). He completed his postdoctoral studies at the Salk Institute for Biological Studies where he identified a novel growth factor, Schwannoma-derived growth factor, as well as activin ([@B28], [@B32], [@B34], [@B71]). He continued working at the Salk Institute as a senior staff scientist, where he identified presenilin-binding protein (PBP), a novel guanine nucleotide exchange factor that activates Rac ([@B27]). PBP was later renamed as modifier of cell adhesion ([@B9], [@B60]), and finally as dedicator of cytokinases 3 (Dock3) ([@B61]).

Summary of Dr. Kimura\'s Top Contributions {#s002}
==========================================

Dr. Kimura showed the first time that hydrogen sulfide (H~2~S) is a novel signaling molecule in multiple body systems. He discovered a physiological role of H~2~S as a mediator of memory formation ([@B1]) ([Fig. 1](#f1){ref-type="fig"}), and subsequently identified another role as a vascular smooth muscle relaxant in synergy with nitric oxide (NO) that was the first demonstration of a crosstalk between H~2~S and NO ([@B21]) ([Fig. 2](#f2){ref-type="fig"}). Prominent neuroscientist Solomon Snyder commented in *Science News*, "They have very impressive evidence that H~2~S is a potential neurotransmitter. It\'s an exciting paper that should stimulate a lot of people\'s interest" ([@B84]).

![**H~2~S modulates the activity of neurons.** H~2~S facilitates the induction of hippocampal LTP, a synaptic model of memory formation **(A)**, by enhancing the activity of NMDA receptor, leaving another type of glutamate receptor, AMPA receptor, unaffected **(B)** ([@B1]). Although a mechanism for the activation of NMDA receptors had been proposed that the reduction of cysteine disulfide bond located at the hinge of the ligand-binding domain by DTT activates the receptor ([@B2]), it is not able to fully explain the activation by a weak reducing molecule such as H~2~S. At much lower concentrations, H~2~S (100 μ*M*) induced LTP more efficiently than 1 m*M* DTT **(C)** ([@B1]). *Lower dotted line:* control EPSP slope; *upper dotted line:* EPSP slope in the presence of DTT. This finding led to the identification of H~2~S~n~ as novel signaling molecules ([@B40], [@B55], [@B59], [@B66]) (see Key Finding 3). AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; DTT, dithiothreitol; EPSP, excitatory post-synaptic potential; H~2~S, hydrogen sulfide; LTP, long-term potentiation; NMDA, *N*-methyl [d]{.smallcaps}-aspartate.](fig-1){#f1}

![**H~2~S relaxes vascular smooth muscle in synergy with NO.** Synergistic effect of H~2~S and NO was discovered on vascular smooth muscle relaxation. The simultaneous application of H~2~S and NO donors induced greater relaxation of vascular smooth muscle than either H~2~S or NO alone ([@B21]). Potentiation of the relaxation effects of Na-nitroprussside **(A)** and morpholinosydnonimine **(B)** by 30 μm NaHS. This finding opened the study of crosstalk between H~2~S and NO and led to the identification of H~2~S~n~ generated by the chemical interaction of both molecules ([@B52]) (see Key Finding 3). NO, nitric oxide.](fig-2){#f2}

Dr. Kimura discovered the cytoprotective effect of H~2~S on neurons from oxidative stress ([@B39]) ([Fig. 3](#f3){ref-type="fig"}), and the effect on other tissues and organs such as heart and kidney was followed ([@B14], [@B85]). These findings led to the identification of numerous physiological roles of this molecule, including anti-inflammation, angiogenesis, oxygen sensing, and ATP formation ([@B11], [@B51], [@B65], [@B67], [@B68], [@B82], [@B93], [@B94]).

![**H~2~S protects neurons from oxidative stress.** Since H~2~S is a well-known toxic gas, its cytoprotective effects have been overlooked. Neurons in primary culture were killed by oxidative stress induced by high concentrations of glutamate, while surviving in the presence of NaHS ([@B39]).](fig-3){#f3}

During further investigation of the physiological roles of H~2~S, Dr. Kimura discovered novel signaling molecules, H~2~S~n~, produced by 3-mercaptopyruvate sulfurtransferase (3MST) ([@B41], [@B42], [@B58], [@B59], [@B66]) ([Fig. 4](#f4){ref-type="fig"}). Since then, studies on H~2~S~n~ have unveiled various physiological roles such as the regulation of ion channels, transcription factors, protein kinases, and tumor suppressors, as well as the production of other per- and polysulfurated molecules ([@B18], [@B41], [@B44], [@B80]). Dr. Kimura also identified H~2~S~n~ produced by the chemical interaction of H~2~S with NO that may provide one of the mechanisms of the synergy between H~2~S and NO ([@B52]) ([Fig. 5](#f5){ref-type="fig"}).

![**H~2~S~n~ induce Ca^2+^ influx in astrocytes.** During the study of the effect of H~2~S on astrocytes, Dr. Kimura\'s group found that a solution of NaHS, a sodium salt of H~2~S whose color is yellowish, activates astrocytes much more efficiently than a colorless solution. The study identified that the yellowish color is derived from H~2~S~n~ generated by the oxidation of H~2~S ([@B40], [@B59], [@B66]). H~2~S~3~ induced Ca^2+^ influx with an EC~50~ value (91 n*M*) **(A, B)**, approximately 1/1000th of that of H~2~S (116 μ*M*) ([@B41]). Time required for the induction of Ca^2+^ influx by Na~2~S~3~ **(C)**. Endogenous H~2~S~2~ and H~2~S~3~ were identified in the brain **(D)** ([@B40], [@B55]). The enlarged peaks a and b are shown in the *inset*. Major peaks for Na~2~S~3~ and Na~2~S~4~ are b and c, respectively. Since the peaks a, b, and c were observed in a control sample with monobrombimane alone, it was subtracted from each peak of the sample to estimate the amount of polysulfides in brain homogenates.](fig-4){#f4}

![**H~2~S~n~ are generated from H~2~S and NO.** Chemical interaction between H~2~S and NO produces H~2~S~2~ and H~2~S~3~ ([@B52]). It may be one of the mechanisms for the synergistic effects of H~2~S and NO on various tissues, including vascular smooth muscle relaxation ([@B12], [@B21]) as shown in [Figure 2](#f2){ref-type="fig"}.](fig-5){#f5}

Description of Key Finding 1 {#s003}
============================

In the library at the Salk Institute, Dr. Kimura found a metabolic map showing mammalian enzymes that can produce H~2~S. These enzymes were intensively studied from the 1950s to 1970s; cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE), and 3MST together with cysteine amino transferase were found to have the capacity *in vitro* ([@B5], [@B8], [@B48], [@B79]), and their full-length cDNAs were cloned in the 1990s ([@B56], [@B62], [@B81]). However, rather than being recognized as a physiologically active molecule in these early studies, H~2~S was thought of simply as a byproduct of metabolic pathways or a marker for the evaluation of enzyme activity.

Three groups discovered endogenous sulfide in mammalian brains when measuring sulfide levels in intoxicated animals ([@B17], [@B70], [@B88]). Survivors of H~2~S poisoning experienced memory loss, and acute intoxication with H~2~S caused changes in the levels of neurotransmitters in the brains of animal models. Inspired by these findings, Dr. Kimura began studying H~2~S as a signaling molecule in 1993 when carbon monoxide had just been identified as a gaseous signaling molecule ([@B47], [@B78], [@B86], [@B95]), following on NO ([@B4], [@B16], [@B23]).

In 1996, Dr. Kimura together with his student Dr. Kazuho Abe demonstrated that H~2~S, which can be produced by CBS in the brain, facilitates the induction of hippocampal long-term potentiation (LTP), a synaptic model of memory formation ([@B1]) ([Figs. 1](#f1){ref-type="fig"} and [6](#f6){ref-type="fig"}). H~2~S enhances the activity of one type of glutamate receptor, *N*-methyl [d]{.smallcaps}-aspartate (NMDA) receptor, leaving another type of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, which is also activated by glutamate, unaffected. A mechanism for the activation of NMDA receptors had been proposed by Aizenman *et al.* using dithiothreitol (DTT), which reduces cysteine disulfide bond located at the hinge of the ligand-binding domain to activate the receptor ([@B2]). However, this mechanism is not able to fully explain the activation by a weak reducing molecule such as H~2~S. At much lower concentrations, H~2~S induced LTP more efficiently than DTT ([Fig. 1](#f1){ref-type="fig"}) ([@B1]). This finding led to the identification of H~2~S~n~ as novel signaling molecules (see Key Finding 3).

![**Facilitation of LTP induction by H~2~S and H~2~S~n~.** H~2~S enhances the activity of NMDA receptors by reducing the cysteine disulfide bond at the hinge of the ligand-binding domain of the receptors ([@B1]). H~2~S~n~ activate TRPA1 channels to induce Ca^2+^ influx in astrocytes ([@B41], [@B59], [@B66]), which, in turn, release gliotransmitters such as [d]{.smallcaps}-serine to enhance the activity of NMDA receptors ([@B77]). By these integrated mechanisms, LTP may be effectively induced. Modified from Kimura ([@B29]). 3MST, 3-mercaptopyruvate sulfurtransferase; CBS, cystathionine β-synthase; TRPA1, transient receptor potential ankyrin 1.](fig-6){#f6}

In 1997, Dr. Kimura demonstrated that H~2~S can be produced by CSE to relax vasculature in synergy with NO ([@B21]) ([Fig. 2](#f2){ref-type="fig"}). This discovery also opened a field of crosstalk between H~2~S and NO (see also Key Finding 3). Subsequently, Wang and colleagues identified K~ATP~ channels as one of the targets of H~2~S to relax vascular smooth muscle ([@B94]), and Cirino and colleagues showed cyclic GMP-dependent protein kinase as another target to mediate H~2~S-induced vasorelaxation ([@B6]).

Description of Key Finding 2 {#s004}
============================

Since H~2~S is a well-known toxic gas, its cytoprotective effects have been overlooked. Dr. Kimura found that H~2~S protects neurons from oxidative stress through enhancing the activity of the cystine/glutamate antiporter and cysteine transporter, as well as γ-glutamyl cysteine synthetase or glutamate cysteine ligase, a rate limiting enzyme in the production of glutathione (GSH), which is a major cellular antioxidant ([@B38], [@B39]) ([Figs. 3](#f3){ref-type="fig"} and [7](#f7){ref-type="fig"}). Dr. Kimura also showed that H~2~S enhances the activity of K~ATP~ and CFTR Cl^-^ channels to suppress the excessive excitation of neurons by stabilizing membrane potential ([@B37]) ([Fig. 7](#f7){ref-type="fig"}). This finding led to the identification of the cytoprotective effect of H~2~S on various tissues and organs, including the heart, kidney, retina, pancreas, and intestines, and the regulation of endoplasmic reticulum stress ([@B14], [@B26], [@B45], [@B49], [@B72], [@B85], [@B93]). Several H~2~S-based therapeutic compounds have been developed, with some undergoing clinical trials ([@B87]). H~2~S even plays an essential role in the development of bacterial resistance to antibiotics ([@B73]). H~2~S is a universal cytoprotectant effective in bacteria and mammals.

![**Protection of neurons from oxidative stress by H~2~S and H~2~S~n~.** H~2~S enhances the activity of the cystine/glutamate antiporter to increase the transport of cystine, which is reduced to cysteine in cells ([@B39]), and also enhances the activity of the cysteine transporter ([@B38]). H~2~S upregulates the activity of a rate limiting enzyme for GSH production, γ-GCS, also known as GCL. By these effects, H~2~S increases the production of GSH. H~2~S also enhances the activity of K~ATP~ channels and CFTR Cl^−^ channels to suppress excessive excitation by stabilizing the membrane potential ([@B37]), while it suppresses the voltage gated Ca^2+^ channels to decrease Ca^2+^ toxicity by enhancing the activity of H^+^-ATPase ([@B49]). In contrast, H~2~S~n~ facilitate the release of Nrf2 from Keap1/Nrf2 complex by sulfurating cysteine residues of Keap1, resulting in the transport of Nrf2 to the nucleus where Nrf2 upregulates the transcription of antioxidant genes, including γ-GCS (GCL) ([@B44]). By these integrated mechanisms, H~2~S and H~2~S~n~ protect neurons from oxidative stress. γ-GCS, γ-glutamyl cysteine synthetase; GCL, glutamate cysteine ligase; GSH, glutathione; Keap1, kelch-like ECH-associated protein 1; Nrf2, nuclear factor-like 2.](fig-7){#f7}

Dr. Kimura\'s group also identified the transcription factor specific protein 1 (SP1)-binding site at the 5′-noncoding region of the CSE gene ([@B25]) that contributes to the cytoprotection *via* NF-κB signaling. Snyder and colleagues identified a mechanism for the antiapoptotic actions induced by tumor necrosis factor alpha (TNFα), where TNFα stimulates the binding of SP1 to the CSE promoter that increases the levels of CSE, resulting in the production of H~2~S. H~2~S S-sulfurates (sulfhydrates) cysteine residues of the p65 subunit of NF-κB to facilitate the interaction with another subunit RPS3, leading to upregulation of antiapoptotic genes ([@B72]).

H~2~S-producing pathway from [d]{.smallcaps}-cysteine that also contributes to cytoprotection was also identified by Dr. Kimura\'s group ([@B74]). [d]{.smallcaps}-Cysteine is metabolized by [d]{.smallcaps}-amino acid oxidase (DAO) to 3-mercaptopyruvate (3MP), which is a substrate of 3MST to produce H~2~S ([@B75], [@B76]). In the kidney, H~2~S production from [d]{.smallcaps}-cysteine is ∼80 times greater than that from [l]{.smallcaps}-cysteine, and the administration of [d]{.smallcaps}-cysteine protects the kidney from ischemia-reperfusion injury more efficiently than that of [l]{.smallcaps}-cysteine. 3MST is a ubiquitous enzyme, whereas DAO is expressed only in restricted tissues, such as the brain and kidney, in mice. This finding may suggest a new therapeutic approach to deliver H~2~S to specific tissues such as the brain and kidney.

Description of Key Finding 3 {#s005}
============================

Astrocytes, a type of glia, were thought to merely support and provide nutrients to neurons, but were recently recognized as actively regulating neuronal activity by releasing gliotransmitters such as [d]{.smallcaps}-serine to synaptic clefts. Dr. Kimura\'s group found that H~2~S induces Ca^2+^ influx in astrocytes ([@B58]). However, during this study, it was found that a solution of NaHS, a sodium salt of H~2~S whose color is yellowish, activates astrocytes much more efficiently than a colorless solution. The study identified that the yellowish color is derived from H~2~S~n~ generated by the oxidation of H~2~S, and it measured the endogenous H~2~S~n~ in the brain ([@B41], [@B42], [@B59], [@B66]) ([Fig. 4](#f4){ref-type="fig"}).

H~2~S~3~ induced Ca^2+^ influx with an EC~50~ value (91 n*M*), approximately 1/1000th of that of H~2~S (116 μ*M*) ([Fig. 4](#f4){ref-type="fig"}). The effect of H~2~S~3~ was suppressed by inhibitors as well as siRNAs specific to transient receptor potential ankyrin 1 (TRPA1) channels, suggesting that H~2~S~3~ activates TRPA1 channels ([@B41]). In collaboration with Dr. Ohta, Dr. Kimura identified the target of H~2~S~3~ as two cysteine residues located at the amino terminus of TRPA1 channels ([@B20]). This finding suggests the additional mechanism for the facilitation of LTP induction (see Key Finding 1, and [Fig. 6](#f6){ref-type="fig"}). H~2~S~n~ activates TRPA1 channels to induce Ca^2+^ influx in astrocytes ([@B41], [@B59], [@B66]), which, in turn, release gliotransmitters such as [d]{.smallcaps}-serine to enhance the activity of NMDA receptors ([@B29], [@B77]).

Other roles of H~2~S~n~ were subsequently found ([@B30]). In collaboration with Dr. Ogasawara, Dr. Kimura found that H~2~S~n~ facilitate the translocation of nuclear factor-like 2 (Nrf2) to the nucleus by modifying its binding partner kelch-like ECH-associated protein 1 (Keap1) to upregulate the transcription of antioxidant genes ([@B44]) ([Fig. 7](#f7){ref-type="fig"}). This system was initially reported to be activated by H~2~S ([@B7]). H~2~S~n~ regulate the activity of the tumor suppressor phosphatase and tensin homolog ([@B18]) and reduce blood pressure by dilating vascular smooth muscle through the activation of protein kinase G1α ([@B80]). These studies facilitated the identification of the production pathways for H~2~S~n~.

Hylin and Wood reported that persulfurated cysteine residues of proteins were produced from 3MP, a substrate of 3MST ([@B22]). Bound sulfane sulfur, which is defined as the sulfur species that releases H~2~S under reducing conditions, includes H~2~S~n~, free cysteine persulfide (Cys-SSH), GSH persulfide (GSSH), and persulfurated cysteine residues of proteins ([@B24], [@B54], [@B63], [@B89]). Dr. Kimura\'s group found that cells expressing 3MST contain higher levels of bound sulfane sulfur than cells expressing defective mutants of 3MST as well as cells without 3MST ([@B76]). Oral administration of [d]{.smallcaps}-cysteine to mice increases the levels of bound sulfane sulfur in the kidney to which DAO is highly localized ([@B74]). As predicted, brains of 3MST knockout mice contain less bound sulfane sulfur than those of wild-type mice ([@B40]). These observations suggested that 3MST can also produce a free form of persulfurated molecules such as H~2~S~n~. In collaboration with Dr. Ogasawara and Dr. Nagahara, Dr. Kimura found that 3MST produces H~2~S~2~ and H~2~S~3~ as well as H~2~S, and determined the endogenous levels of both molecules ([@B40], [@B42], [@B43], [@B55]).

During studies on H~2~S~n~ production by 3MST, Dr. Kimura\'s group noticed that levels of cysteine and GSH were decreased when 3MST produces H~2~S~n~. Dr. Kimura concluded that H~2~S~n~ readily reacted with Cys-SH and GSH to produce Cys-SSH and GSSH ([@B40]). Alternatively, 3MST may transfer sulfur from 3MP to cysteine and GSH to produce these persulfurated species ([Fig. 8](#f8){ref-type="fig"}).

![**Production of H~2~S, H~2~S~n~, Cys-SSH, GSSH, and S-sulfurated proteins by 3MST and the effects of these molecules.** 3MST produces H~2~S~n~ and H~2~S by interacting with thioredoxin (Trx) ([@B40], [@B50]). H~2~S~n~ are also generated by the interaction of H~2~S with NO or the oxidation of H~2~S ([@B52]). 3MST can also produce Cys-SSH and GSSH directly or through the generation of H~2~S~n~, which readily react with Cys-SH and GSH ([@B40]). H~2~S reduces the cysteine disulfide bond to induce the conformational changes of target proteins, resulting in the regulation of their activity ([@B1]). H~2~S~n~ S-sulfurate (sulfhydrate) cysteine residues of target proteins ([@B54]), whereas under oxidative stress or by NO signaling (*dotted box*) H~2~S S-sulfurates the oxidized cysteine residues such as nitrosylated (Cys-SNO) and sulfenic acid (Cys-SOH) to regulate the activity of targets. (Reprinting from Ref. 31). CSE, cystathionine γ-lyase.](fig-8){#f8}

3MST requires a reducing substance to produce H~2~S, but an endogenous reducing substance was not known. From the structure of leishmania 3MST, which contains a thioredoxin domain in the molecule, the interaction of thioredoxin with 3MST had been predicted ([@B90]). Dr. Kimura\'s group determined thioredoxin as well as dihydrolipoic acid as potential endogenous reducing molecules necessary for 3MST to produce H~2~S ([@B50], [@B57], [@B92]).

3MST thiolates tRNA to maintain the accuracy of the genetic code and stabilize the tRNA structure ([@B46], [@B91]). There are two isoforms of 3MST that localize to the cytosol and mitochondria in humans ([@B15]). Cytosolic isoforms thiolate tRNA, whereas the mitochondrial isoform has a dual localization in both mitochondria and the cytosol, and not only thiolates tRNA in the cytosol but also supplies sulfur for iron--sulfur cluster formation in mitochondria ([@B15]). It is interesting to note that cysteinyl-tRNA synthetase was recently reported to have the activity to produce Cys-SSH ([@B3]).

Eberhardt *et al.* and Cortese-Krott *et al.* reported that the chemical interaction of H~2~S with NO produces HNO and SSNO^−^, respectively ([@B10], [@B13]). Both groups showed H~2~S~n~ formation, but they did not consider their physiological relevance. Whereas Eberhardt *et al.* concluded that HNO is the chemical species responsible for activating the TRPA1-CGRP neuroendocrine signaling cascade and postulated that this pathway is essential for control of the general vascular tone, Dr. Kimura\'s group determined that H~2~S~2~ and H~2~S~3~ are the molecules that activate the TRPA1 channels of dorsal root ganglion neurons ([@B52]) ([Fig. 5](#f5){ref-type="fig"}). Mustafa and Habara reported that H~2~S~n~ must be produced by the interaction of H~2~S and NO in mast cells ([@B53]). Molecules, which are produced from H~2~S and NO and activate TRPA1 channels, and H~2~S~n~ are degraded by cyanide (cyanolysis) and by reduction ([@B52]). In contrast, HNO is resistant to cyanolysis and SSNO^−^ to reduction ([@B10], [@B13]). Considering these observations, Kimura\'s group suggested that the production of H~2~S~n~ from H~2~S and NO may be one of the mechanisms for the synergistic effects of both molecules on various tissues, including vascular smooth muscle relaxation ([@B12], [@B21]).

Other Achievements {#s006}
==================

In collaboration with Dr. Nagano, Dr. Urano, and Dr. Hanaoka, Dr. Kimura\'s group contributed to the development of H~2~S- and polysulfide-fluorescence probes ([@B52], [@B69], [@B83]) as well as inhibitors specific to 3MST ([@B19]).

Current Position {#s007}
================

Dr. Kimura is a specially appointed researcher, National Institute of Neuroscience, National Center of Neurology and Psychiatry. He was recently appointed as Professor and Faculty of Pharmaceutical Science at the Tokyo University of Science, Yamaguchi (renamed Sanyo-Onoda City University in 2018), Japan.

He received the Promoting Award from the Japanese Pharmacological Society (1988), Human Frontier Science Program (1990), First Award from National Institute of Health (1994), Alzheimer Scholar Award from Alzheimer Association (1994), JB Award from Japanese Biological Society (2010), Research Front Award from Thomson Reuters (2016), Highly Cited Researcher from Clarivate Analytics (2017), and President Award from the National Institute of Neuroscience, National Center of Neurology and Psychiatry (2018). He has served as a nominator of Japan Prize since 2008.

Supplementary Material
======================
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Dr. Hideo Kimura would like to thank Professor David Schubert for encouraging and supporting him to promote the study of hydrogen sulfide. He also thanks late Professor Yutaka Sakai, Professors Hideomi Fukuda, Hiroshi Saito, Toshiharu Nagatsu, Sadaaki Iwanaga, Keizo Inoue, and Eijiro Ozawa for their suggestions and for supporting him. Dr. Kimura thanks all colleagues during their stay in the laboratories for their contribution to the study: Drs. Kazuho Abe, Norihiro Shibuya, Isao Ishii, Yasushi Enokido, Yasuo Nagai, Ken Umemura, Yoshinori Mikami, Kazuhiko Namekata, Mamiko Tsugane, Mari Ishigami, Shin Koike, Noriyuki Akahoshi, Yuriko Kobayashi, Makiko Tanaka, Yukiko Toyofuku, Ryo Miyamoto, and Yuka Kimura. He also thanks Professors Norio Matsuki, Makoto Suematsu, Yuki Ogasawara, Sachio Takashima, Noriyuki Nagahara, David Lefer, Kazuyuki Ishii, Tetsuo Nagano, Yasuteru Urano, Kenjiro Hanaoka, Toshihide Kimura, Yukiko Kaneko, Rumiko Hosoki, Akiko Ichinohe, Takeshi Kanaumi, and late Professor Ichiro Niki for their collaborations.
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